Press release
Infectious Disease Diagnostics Market worth $33.1 billion by 2027 - Leading Key Players are Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France)
According to the new market research report "Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) - Global Forecast to 2027", published by MarketsandMarkets™, is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR.Browse in-depth TOC on "Infectious Disease Diagnostics Market"
164 - Tables
51 - Figures
294 - Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589&utm_source=openpr&utm_medium=referral
The global prevalence of infectious diseases and the growing awareness for early disease diagnosis, shift in focus from centralized laboratories to decentralized POC testing and rising technological advancements are factors supporting the growth of this market. Growth opportunities in growing economies provide lucrative opportunities for the players operating in the infectious disease diagnostic market.
The reagents, kits, and consumables segment accounted for the largest share of the infectious disease diagnostics market, by product & service segment, in 2021
Based on product & service, the infectious disease diagnostic market is segmented into reagents, kits, and consumables; instruments; and software & services. In 2021, the reagents, kits, and consumables segment accounted for the largest share of this market. The requirement of reagents, kits, and consumables in large numbers compared to instruments is the main factor contributing to the large share of this segment. Unlike instruments, reagents, kits, and consumables segment requires repeat purchases, which results in its stable demand among end users.
POC testing segment to register the highest CAGR during the forecast period
Based on the type of testing, the infectious disease diagnostics market has been segmented into laboratory testing and POC testing. In 2021, the POC testing segment accounted for the highest CAGR. This can be attributed to the need to closely monitor patient conditions and advantages such as faster diagnosis.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589&utm_source=openpr&utm_medium=referral
The COVID-19 segment accounted for the largest share of the infectious disease diagnostics market, by disease type segment, in 2021
Based on disease type, the market is segmented into COVID-19, HIV, HAIs, hepatitis, CT, NG, HPV, Tuberculosis, influenza, syphilis, mosquito-borne diseases and other infectious diseases. In 2021, the COVID-19 disease type segment accounted for the largest share of this market due to factors such as the increasing number of cases and the availability of many COVID-19 diagnostic tests.
The diagnostic laboratories segment accounted for the largest share of the infectious disease diagnostics market, by end user segment, in 2021
Based on end user, the infectious disease diagnostic market has been segmented into diagnostic laboratories, hospitals & clinics, academic research institutes, and other end users. In 2021, diagnostic laboratories accounted for the largest share of the market. Diagnostic laboratories command the major share of the market owing to increased test volume of infectious diseases and strengthening healthcare infrastructure for efficient disease diagnosis and treatment.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=116764589&utm_source=openpr&utm_medium=referral
North America is the largest regional market for infectious disease diagnostics market
The infectious disease diagnostic market is segmented into five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of the market. The large share of this region can be attributed to the highly developed healthcare system in the US and Canada, the presence of many leading national clinical laboratories, and the easy accessibility to technologically advanced instruments.
The major players operating in this infectious disease diagnostics market are Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Siemens Healthineers AG (Germany), Danaher Corporation (US), Becton, Dickinson and Company (US), PerkinElmer, Inc. (US), Hologic, Inc. (US), QIAGEN N.V. (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics Holdings plc (US), Quidel Corporation (US), Meridian Bioscience (US), Genetic Signatures Ltd. (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems (US), Seegene, Inc. (South Korea), Co-Diagnostics (US), ELITechGroup (France), Epitope Diagnostics (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International (US), Vela Diagnostics (Singapore) and Uniogen Oy (Finland).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Infectious Disease Diagnostics Market worth $33.1 billion by 2027 - Leading Key Players are Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France) here
News-ID: 2655313 • Views: …
More Releases from MarketsandMarkets™.

Bone Growth Stimulator Market worth $1.8 billion by 2027 - Leading Key Players a …
- Bone Growth Stimulator Market is projected to grow from USD 1.4 billion in 2022 to USD 1.8 billion by 2027, at a CAGR of 5.9% from 2022 to 2027, according to a new report by MarketsandMarkets™. The growth of the global bone growth stimulators market can be attributed to factors such as increasing research activities for the development of novel bone growth stimulators devices, growing demand for bone growth…

Protein Expression Market worth $5.4 billion by 2027 - Exclusive Report by Marke …
Protein Expression Market is projected to grow from USD 2.9 billion in 2022 to USD 5.4 billion by 2027, at a CAGR of 13.3% from 2022 to 2027, according to a study published by MarketsandMarkets™. The Factors such as the increasing incidence of chronic diseases, increasing research activities on recombinant-based protein expression, growth in the life sciences and biopharmaceutical industries, as well as the availability of funding for protein-based research.…

OTC Braces & Supports Market worth $1,286 million by 2027 - Exclusive Report by …
The OTC Braces and Supports Market is valued at an estimated USD 942 million in 2022 and is projected to reach USD 1,286 million by 2027, at a CAGR of 6.4%, according to a new report by MarketsandMarkets™. Market growth is driven by the rising technological advancements in OTC braces and supports, increasing orthopedic disorders and the growing awareness of preventive diagnosis in developing countries. Emerging economies such as China,…

Artificial Intelligence (AI) in Medical Diagnostics Market worth $5.5 billion by …
Artificial Intelligence (AI) in Medical Diagnostics Market is projected to grow from USD 1.0 billion in 2022 to USD 5.5 billion by 2027, at a CAGR of 39.9% from 2022 to 2027, according to a new report by MarketsandMarkets™. The application of AI in medical diagnostics is growing at a fast pace owing to factors such as growing government initiatives to drive the adoption of AI-based technologies, rise in adoption…
More Releases for Diagnostic
Rubella Diagnostic Testing Market Report 2024 - Rubella Diagnostic Testing Marke …
"The Business Research Company recently released a comprehensive report on the Global Rubella Diagnostic Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Diagnostic Electrocardiograph Market - Elevating Cardiac Care: Diagnostic Electr …
Newark, New Castle, USA: The "Diagnostic Electrocardiograph Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Diagnostic Electrocardiograph Market: https://www.growthplusreports.com/report/diagnostic-electrocardiograph-market/7804
This latest report researches the industry structure, sales, revenue,…
Diagnostic Imaging Market - Empowering Precision Medicine: Harnessing the Potent …
Newark, New Castle, USA: The "Diagnostic Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2021 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Diagnostic Imaging Market: https://www.growthplusreports.com/report/diagnostic-imaging-market/7688
This latest report researches the industry structure, sales, revenue,…
Rubella Diagnostic Testing Market - Advancing Rubella Control: Innovating Diagno …
Newark, New Castle, USA - new report, titled Rubella Diagnostic Testing Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Rubella Diagnostic Testing market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Rubella Diagnostic Testing market. The report offers an overview of…
Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects.
Tenet Diagnostics got its NABL certification in the fastest time and is…
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends…